![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1489, 2005-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Naproxen/sumatriptan tops either drug alone for migraine
Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intranasal Sumatriptan: In Adolescents with Migraine
By Curran Monique P. Evans Hannah C. Wagstaff Antona J.
CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral Sumatriptan Pharmacokinetics in the Migraine State
By Sramek J.J.
Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Low Efficacy of Transdermal Sumatriptan in Migraine
CNS Drugs, Vol. 25, Iss. 2, 2011-02 ,pp. :